Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0020023 | kinetoplast | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.688 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.459 |
CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.722 |
CLV_PCSK_KEX2_1 | 49 | 51 | PF00082 | 0.459 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.670 |
DOC_CKS1_1 | 25 | 30 | PF01111 | 0.635 |
DOC_MAPK_MEF2A_6 | 95 | 104 | PF00069 | 0.446 |
DOC_PP1_RVXF_1 | 47 | 54 | PF00149 | 0.461 |
DOC_PP4_FxxP_1 | 73 | 76 | PF00568 | 0.506 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.427 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.642 |
LIG_14-3-3_CanoR_1 | 13 | 17 | PF00244 | 0.681 |
LIG_14-3-3_CanoR_1 | 30 | 35 | PF00244 | 0.512 |
LIG_14-3-3_CanoR_1 | 49 | 54 | PF00244 | 0.448 |
LIG_LIR_Apic_2 | 71 | 76 | PF02991 | 0.494 |
LIG_REV1ctd_RIR_1 | 37 | 46 | PF16727 | 0.480 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.498 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.552 |
MOD_CDK_SPxK_1 | 24 | 30 | PF00069 | 0.637 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.496 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.558 |
MOD_CK2_1 | 112 | 118 | PF00069 | 0.473 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.587 |
MOD_LATS_1 | 47 | 53 | PF00433 | 0.481 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.427 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.455 |
MOD_PK_1 | 30 | 36 | PF00069 | 0.510 |
MOD_PKA_1 | 49 | 55 | PF00069 | 0.460 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.683 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.460 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.422 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.642 |
TRG_ER_diArg_1 | 49 | 51 | PF00400 | 0.459 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHE6 | Leptomonas seymouri | 91% | 91% |
A0A1X0P6R5 | Trypanosomatidae | 72% | 100% |
A0A3Q8ICZ2 | Leishmania donovani | 100% | 100% |
A0A3S5IS44 | Trypanosoma rangeli | 76% | 100% |
A4H9D0 | Leishmania braziliensis | 94% | 100% |
B6DTE3 | Bodo saltans | 74% | 100% |
D0A030 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 76% | 100% |
E9ARG3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4QE16 | Leishmania major | 98% | 100% |